{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:25:20Z","timestamp":1790342720329,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/cdd.2017.153","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T14:31:22Z","timestamp":1506090682000},"page":"268-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["A vitronectin-derived peptide reverses ovariectomy-induced bone loss via regulation of osteoblast and osteoclast differentiation"],"prefix":"10.1038","volume":"25","author":[{"given":"Seung-Ki","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ki","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Youn","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Hyun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Moo","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,22]]},"reference":[{"key":"BFcdd2017153_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00113-006-1152-z","volume":"109","author":"M Schieker","year":"2006","unstructured":"Schieker M, Mutschler W . Bridging posttraumatic bony defects. Established and new methods. Unfallchirurg 2006; 109: 715\u2013732.","journal-title":"Unfallchirurg"},{"key":"BFcdd2017153_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0142-9612(96)85762-0","volume":"17","author":"MJ Yaszemski","year":"1996","unstructured":"Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG . Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 1996; 17: 175\u2013185.","journal-title":"Biomaterials"},{"key":"BFcdd2017153_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ijom.2004.04.005","volume":"33","author":"HP Wiesmann","year":"2004","unstructured":"Wiesmann HP, Joos U, Meyer U . Biological and biophysical principles in extracorporal bone tissue engineering. Part II. Int J Oral Maxillofac Surg 2004; 33: 523\u2013530.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"BFcdd2017153_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.0105-2896.2005.00327.x","volume":"208","author":"S Tanaka","year":"2005","unstructured":"Tanaka S, Nakamura K, Takahasi N, Suda T . Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev 2005; 208: 30\u201349.","journal-title":"Immunol Rev"},{"key":"BFcdd2017153_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1517\/14728222.2011.546351","volume":"15","author":"ML Broadhead","year":"2011","unstructured":"Broadhead ML, Clark JC, Dass CR, Choong PF, Myers DE . Therapeutic targeting of osteoclast function and pathways. Expert Opin Ther Targets 2011; 15: 169\u2013181.","journal-title":"Expert Opin Ther Targets"},{"key":"BFcdd2017153_CR6","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1517\/13543776.2013.842556","volume":"23","author":"SH Kim","year":"2013","unstructured":"Kim SH, Moon SH . Osteoclast differentiation inhibitors: a patent review (2008 - 2012). Expert Opin Ther Pat 2013; 23: 1591\u20131610.","journal-title":"Expert Opin Ther Pat"},{"key":"BFcdd2017153_CR7","first-page":"1","volume":"93","author":"AC Looker","year":"2012","unstructured":"Looker AC, Borrud LG, Dawson-Hughes B, Shepherd JA, Wright NC . Osteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005-2008. NCHS Data Brief 2012; 93: 1\u20138.","journal-title":"NCHS Data Brief"},{"key":"BFcdd2017153_CR8","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/jbmr.2269","volume":"29","author":"NC Wright","year":"2014","unstructured":"Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 2014; 29: 2520\u20132526.","journal-title":"J Bone Miner Res"},{"key":"BFcdd2017153_CR9","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.spinee.2013.06.010","volume":"13","author":"SB Park","year":"2013","unstructured":"Park SB, Park SH, Kim NH, Chung CK . BMP-2 induced early bone formation in spine fusion using rat ovariectomy osteoporosis model. Spine J 2013; 13: 1273\u20131280.","journal-title":"Spine J"},{"key":"BFcdd2017153_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/cbdd.12055","volume":"81","author":"DJ Craik","year":"2013","unstructured":"Craik DJ, Fairlie DP, Liras S, Price D . The future of peptide-based drugs. Chem Biol Drug Des 2013; 81: 136\u2013147.","journal-title":"Chem Biol Drug Des"},{"key":"BFcdd2017153_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.tibtech.2012.07.005","volume":"30","author":"S Bose","year":"2012","unstructured":"Bose S, Roy M, Bandyopadhyay A . Recent advances in bone tissue engineering scaffolds. Trends Biotechnol 2012; 30: 546\u2013554.","journal-title":"Trends Biotechnol"},{"key":"BFcdd2017153_CR12","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/nbt1197-1266","volume":"15","author":"W Takasaki","year":"1997","unstructured":"Takasaki W, Kajino Y, Kajino K, Murali R, Greene MI . Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF\u03b1 binding to its receptor. Nat Biotechnol 1997; 15: 1266\u20131270.","journal-title":"Nat Biotechnol"},{"key":"BFcdd2017153_CR13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.addr.2012.05.017","volume":"64","author":"K Aoki","year":"2012","unstructured":"Aoki K, Alles N, Soysa N, Ohya K . Peptide-based delivery to bone. Adv Drug Deliv Rev 2012; 64: 1220\u20131238.","journal-title":"Adv Drug Deliv Rev"},{"key":"BFcdd2017153_CR14","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1089\/ten.2006.12.3509","volume":"12","author":"M Dettin","year":"2006","unstructured":"Dettin M, Bagno A, Morpurgo M, Cacchioli A, Conconi MT, Di Bello C et al. Evaluation of silicon dioxide-based coating enriched with bioactive peptides mapped on human vitronectin and fibronectin: in vitro and in vivo assays. Tissue Eng 2006; 12: 3509\u20133523.","journal-title":"Tissue Eng"},{"key":"BFcdd2017153_CR15","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.2174\/138161211797416011","volume":"17","author":"JY Lee","year":"2011","unstructured":"Lee JY, Choi YS, Lee SJ, Chung CP, Park YJ . Bioactive peptide-modified biomaterials for bone regeneration. Curr Pharm Des 2011; 17: 2663\u20132676.","journal-title":"Curr Pharm Des"},{"key":"BFcdd2017153_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/molecules16010857","volume":"16","author":"P Molek","year":"2011","unstructured":"Molek P, Strukelj B, Bratkovic T . Peptide phage display as a tool for drug discovery: targeting membrane receptors. Molecules 2011; 16: 857\u2013887.","journal-title":"Molecules"},{"key":"BFcdd2017153_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/PPO.0b013e318233e5b2","volume":"17","author":"CL Slingluff Jr.","year":"2011","unstructured":"Slingluff CL Jr. . The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination? Cancer J 2011; 17: 343\u2013350.","journal-title":"Cancer J"},{"key":"BFcdd2017153_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2165\/00024677-200201030-00005","volume":"1","author":"JF Whitfield","year":"2002","unstructured":"Whitfield JF, Morley P, Willick GE . Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis. Treat Endocrinol 2002; 1: 175\u2013190.","journal-title":"Treat Endocrinol"},{"key":"BFcdd2017153_CR19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00198-009-1004-0","volume":"21","author":"V Subbiah","year":"2010","unstructured":"Subbiah V, Madsen VS, Raymond AK, Benjamin RS, Ludwig JA . Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int 2010; 21: 1041\u20131045.","journal-title":"Osteoporos Int"},{"key":"BFcdd2017153_CR20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.biocel.2009.12.018","volume":"42","author":"Q Zhao","year":"2010","unstructured":"Zhao Q, Wang X, Liu Y, He A, Jia R . NFATc1: functions in osteoclasts. Int J Biochem Cell Biol 2010; 42: 576\u2013579.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFcdd2017153_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.tem.2012.05.005","volume":"23","author":"T Nakashima","year":"2012","unstructured":"Nakashima T, Hayashi M, Takayanagi H . New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab 2012; 23: 582\u2013590.","journal-title":"Trends Endocrinol Metab"},{"key":"BFcdd2017153_CR22","first-page":"65","volume":"59","author":"NS Soysa","year":"2012","unstructured":"Soysa NS, Alles N, Aoki K, Ohya K . Osteoclast formation and differentiation: an overview. J Med Dent Sci 2012; 59: 65\u201374.","journal-title":"J Med Dent Sci"},{"key":"BFcdd2017153_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165\u2013176.","journal-title":"Cell"},{"key":"BFcdd2017153_CR24","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nm.2448","volume":"17","author":"J Xiong","year":"2011","unstructured":"Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA . Matrix-embedded cells control osteoclast formation. Nat Med 2011; 17: 1235\u20131241.","journal-title":"Nat Med"},{"key":"BFcdd2017153_CR25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002; 3: 889\u2013901.","journal-title":"Dev Cell"},{"key":"BFcdd2017153_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H . Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007; 7: 292\u2013304.","journal-title":"Nat Rev Immunol"},{"key":"BFcdd2017153_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.abb.2008.04.004","volume":"473","author":"T Nakashima","year":"2008","unstructured":"Nakashima T, Takayanagi H . The dynamic interplay between osteoclasts and the immune system. Arch Biochem Biophys 2008; 473: 166\u2013171.","journal-title":"Arch Biochem Biophys"},{"key":"BFcdd2017153_CR28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1084\/jem.20051150","volume":"202","author":"M Asagiri","year":"2005","unstructured":"Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 2005; 202: 1261\u20131269.","journal-title":"J Exp Med"},{"key":"BFcdd2017153_CR29","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1172\/JCI35711","volume":"118","author":"AO Aliprantis","year":"2008","unstructured":"Aliprantis AO, Ueki Y, Sulyanto R, Park A, Sigrist KS, Sharma SM et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest 2008; 118: 3775\u20133789.","journal-title":"J Clin Invest"},{"key":"BFcdd2017153_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1172\/JCI3212","volume":"102","author":"LT Duong","year":"1998","unstructured":"Duong LT, Lakkakorpi PT, Nakamura I, Machwate M, Nagy RM, Rodan GA . PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of \u03b1v\u03b23 integrin, and phosphorylated by src kinase. J Clin Invest 1998; 102: 881\u2013892.","journal-title":"J Clin Invest"},{"key":"BFcdd2017153_CR31","unstructured":"Boron WF, Boulpaep EL (eds.)Medical Physiology. Saunders: New York, NY, USA, 2012."},{"key":"BFcdd2017153_CR32","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.1016\/S0021-9258(18)98408-5","volume":"268","author":"RC Cherny","year":"1993","unstructured":"Cherny RC, Honan MA, Thiagarajan P . Site-directed mutagenesis of the arginine-glycine-aspartic acid in vitronectin abolishes cell adhesion. J Biol Chem 1993; 268: 9725\u20139729.","journal-title":"J Biol Chem"},{"key":"BFcdd2017153_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1326-3-16","volume":"3","author":"TM Shin","year":"2008","unstructured":"Shin TM, Isas JM, Hsieh CL, Kayed R, Glabe CG, Langen R et al. Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin. Mol Neurodegener 2008; 3: 16.","journal-title":"Mol Neurodegener"},{"key":"BFcdd2017153_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0092-8674(92)90115-S","volume":"69","author":"RO Hynes","year":"1992","unstructured":"Hynes RO . Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11\u201325.","journal-title":"Cell"},{"key":"BFcdd2017153_CR35","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1074\/jbc.M605666200","volume":"282","author":"G Mandicourt","year":"2007","unstructured":"Mandicourt G, Iden S, Ebnet K, Aurrand-Lions M, Imhof BA . JAM-C regulates tight junctions and integrin-mediated cell adhesion and migration. J Biol Chem 2007; 282: 1830\u20131837.","journal-title":"J Biol Chem"},{"key":"BFcdd2017153_CR36","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1128\/MCB.19.7.4806","volume":"19","author":"JD Owen","year":"1999","unstructured":"Owen JD, Ruest PJ, Fry DW, Hanks SK . Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Mol Cell Biol 1999; 19: 4806\u20134818.","journal-title":"Mol Cell Biol"},{"key":"BFcdd2017153_CR37","doi-asserted-by":"publisher","first-page":"14845","DOI":"10.1074\/jbc.M606695200","volume":"282","author":"JK Slack-Davis","year":"2007","unstructured":"Slack-Davis JK, Martin KH, Tilghman RW, Iwanicki M, Ung EJ, Autry C et al. Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 2007; 282: 14845\u201314852.","journal-title":"J Biol Chem"},{"key":"BFcdd2017153_CR38","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1016\/j.biomaterials.2010.01.075","volume":"31","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim CS, Choi KH, Jung UW, Yun JH, Choi SH et al. The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli. Biomaterials 2010; 31: 3512\u20133519.","journal-title":"Biomaterials"},{"key":"BFcdd2017153_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbrc.2006.10.011","volume":"351","author":"H Huang","year":"2006","unstructured":"Huang H, Chang EJ, Ryu J, Lee ZH, Lee Y, Kim HH . Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem Biophys Res Commun 2006; 351: 99\u2013105.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcdd2017153_CR40","doi-asserted-by":"publisher","first-page":"18245","DOI":"10.1074\/jbc.M610701200","volume":"282","author":"T Yamashita","year":"2007","unstructured":"Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM et al. NF-\u03baB p50 and p52 regulate receptor activator of NF-\u03baB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem 2007; 282: 18245\u201318253.","journal-title":"J Biol Chem"},{"key":"BFcdd2017153_CR41","doi-asserted-by":"publisher","first-page":"11502","DOI":"10.1074\/jbc.M206579200","volume":"278","author":"PT Lakkakorpi","year":"2003","unstructured":"Lakkakorpi PT, Bett AJ, Lipfert L, Rodan GA, Duong LT . PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption. J Biol Chem 2003; 278: 11502\u201311512.","journal-title":"J Biol Chem"},{"key":"BFcdd2017153_CR42","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1128\/MCB.00077-12","volume":"32","author":"T Izawa","year":"2012","unstructured":"Izawa T, Zou W, Chappel JC, Ashley JW, Feng X, Teitelbaum SL . c-Src links a RANK\/\u03b1v\u03b23 integrin complex to the osteoclast cytoskeleton. Mol Cell Biol 2012; 32: 2943\u20132953.","journal-title":"Mol Cell Biol"},{"key":"BFcdd2017153_CR43","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1083\/jcb.200611083","volume":"176","author":"W Zou","year":"2007","unstructured":"Zou W, Kitaura H, Reeve J, Long F, Tybulewicz VL, Shattil SJ et al. Syk, c-Src, the \u03b1v\u03b23 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol 2007; 176: 877\u2013888.","journal-title":"J Cell Biol"},{"key":"BFcdd2017153_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1600-0757.2006.00157.x","volume":"41","author":"G Polimeni","year":"2006","unstructured":"Polimeni G, Xiropaidis AV, Wikesjo UM . Biology and principles of periodontal wound healing\/regeneration. Periodontol 2000 2006; 41: 30\u201347.","journal-title":"Periodontol 2000"},{"key":"BFcdd2017153_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cden.2009.08.011","volume":"54","author":"CC Villar","year":"2010","unstructured":"Villar CC, Cochran DL . Regeneration of periodontal tissues: guided tissue regeneration. Dent Clin North Am 2010; 54: 73\u201392.","journal-title":"Dent Clin North Am"},{"key":"BFcdd2017153_CR46","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/380538a0","volume":"380","author":"A Richardson","year":"1996","unstructured":"Richardson A, Parsons T . A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature 1996; 380: 538\u2013540.","journal-title":"Nature"},{"key":"BFcdd2017153_CR47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","volume":"64","author":"P Soriano","year":"1991","unstructured":"Soriano P, Montgomery C, Geske R, Bradley A . Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991; 64: 693\u2013702.","journal-title":"Cell"},{"key":"BFcdd2017153_CR48","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nm.3586","volume":"20","author":"B Yu","year":"2014","unstructured":"Yu B, Chang J, Liu Y, Li J, Kevork K, Al-Hezaimi K et al. Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-\u03baB. Nat Med 2014; 20: 1009\u20131017.","journal-title":"Nat Med"},{"key":"BFcdd2017153_CR49","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1172\/JCI28550","volume":"116","author":"MN Weitzmann","year":"2006","unstructured":"Weitzmann MN, Pacifici R . Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 2006; 116: 1186\u20131194.","journal-title":"J Clin Invest"},{"key":"BFcdd2017153_CR50","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.biomaterials.2003.08.045","volume":"25","author":"BM Min","year":"2004","unstructured":"Min BM, Lee G, Kim SH, Nam YS, Lee TS, Park WH . Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials 2004; 25: 1289\u20131297.","journal-title":"Biomaterials"},{"key":"BFcdd2017153_CR51","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1021\/bm700875a","volume":"9","author":"IS Yeo","year":"2008","unstructured":"Yeo IS, Oh JE, Jeong L, Lee TS, Lee SJ, Park WH et al. Collagen-based biomimetic nanofibrous scaffolds: preparation and characterization of collagen\/silk fibroin bicomponent nanofibrous structures. Biomacromolecules 2008; 9: 1106\u20131116.","journal-title":"Biomacromolecules"},{"key":"BFcdd2017153_CR52","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/ncb0901-778","volume":"3","author":"JG Toma","year":"2001","unstructured":"Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, Kaplan DR et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001; 3: 778\u2013784.","journal-title":"Nat Cell Biol"},{"key":"BFcdd2017153_CR53","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/ncb1181","volume":"6","author":"KJ Fernandes","year":"2004","unstructured":"Fernandes KJ, McKenzie IA, Mill P, Smith KM, Akhavan M, Barnabe-Heider F et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 2004; 6: 1082\u20131093.","journal-title":"Nat Cell Biol"},{"key":"BFcdd2017153_CR54","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.yexcr.2004.11.009","volume":"304","author":"JM Kim","year":"2005","unstructured":"Kim JM, Park WH, Min BM . The PPFLMLLKGSTR motif in globular domain 3 of the human laminin-5 \u03b13 chain is crucial for integrin \u03b13\u03b21 binding and cell adhesion. Exp Cell Res 2005; 304: 317\u2013327.","journal-title":"Exp Cell Res"},{"key":"BFcdd2017153_CR55","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","volume":"16","author":"LJ McGuffin","year":"2000","unstructured":"McGuffin LJ, Bryson K, Jones DT . The PSIPRED protein structure prediction server. Bioinformatics 2000; 16: 404\u2013405.","journal-title":"Bioinformatics"},{"key":"BFcdd2017153_CR56","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1089\/scd.2008.0260","volume":"18","author":"JF Lavoie","year":"2009","unstructured":"Lavoie JF, Biernaskie JA, Chen Y, Bagli D, Alman B, Kaplan DR et al. Skin-derived precursors differentiate into skeletogenic cell types and contribute to bone repair. Stem Cells Dev 2009; 18: 893\u2013905.","journal-title":"Stem Cells Dev"},{"key":"BFcdd2017153_CR57","first-page":"e962","volume":"3","author":"RT B\u00f6ttcher","year":"2013","unstructured":"B\u00f6ttcher RT . \u03b21 integrin cell-surface immunoprecipitation (selective immunoprecipitation). Bioprotocol 2013; 3: e962.","journal-title":"Bioprotocol"},{"key":"BFcdd2017153_CR58","doi-asserted-by":"publisher","first-page":"13725","DOI":"10.1074\/jbc.M806941200","volume":"284","author":"JH Lee","year":"2009","unstructured":"Lee JH, Kim HN, Yang D, Jung K, Kim HM, Kim HH et al. Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling. J Biol Chem 2009; 284: 13725\u201313734.","journal-title":"J Biol Chem"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd2017153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2017153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cdd.2017.153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2017153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:12:26Z","timestamp":1684415546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd2017153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFcdd2017153"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2017.153","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,22]]},"assertion":[{"value":"1 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}